Viral MicroRNA Targetome of KSHV-Infected Primary Effusion Lymphoma Cell Lines

被引:257
|
作者
Gottwein, Eva [1 ]
Corcoran, David L. [2 ]
Mukherjee, Neelanjan [2 ]
Skalsky, Rebecca L. [4 ]
Hafner, Markus [5 ,6 ]
Nusbaum, Jeffrey D. [5 ,6 ]
Shamulailatpam, Priscilla [1 ]
Love, Cassandra L. [2 ]
Dave, Sandeep S. [2 ]
Tuschl, Thomas [5 ,6 ]
Ohler, Uwe [2 ,3 ]
Cullen, Bryan R. [4 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA
[2] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA
[3] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA
[4] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
[5] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA
[6] Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
SARCOMA-ASSOCIATED HERPESVIRUS; VIRUS-ENCODED MICRORNAS; HUMAN GAMMA-HERPESVIRUSES; EPSTEIN-BARR-VIRUS; PROTEIN EXPRESSION; MESSENGER-RNAS; DNA-SEQUENCES; PAR-CLIP; IDENTIFICATION; MIR-155;
D O I
10.1016/j.chom.2011.09.012
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
引用
收藏
页码:515 / 526
页数:12
相关论文
共 50 条
  • [21] Extracavitary KSHV-associated Large B-Cell Lymphoma A Distinct Entity or a Subtype of Primary Effusion Lymphoma? Study of 9 Cases and Review of an Additional 43 Cases
    Pan, Zeng-Gang
    Zhang, Qian-Yun
    Lu, Zheng-Bin
    Quinto, Tobi
    Rozenvald, Igor B.
    Liu, Lan-Ting
    Wilson, David
    Reddy, Vishnu
    Huang, Qing
    Wang, Huan-You
    Ren, Yong-Sheng
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (08) : 1129 - 1140
  • [22] Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition
    Li, Xiaojuan
    Wang, Fan
    Zhang, Xiaolin
    Sun, Qinqin
    Kuang, Ersheng
    PLOS PATHOGENS, 2023, 19 (01)
  • [23] Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines
    Wu, Yiquan
    Wang, Victoria
    Yarchoan, Robert
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [24] Primary effusion lymphoma: therapeutic strategies targeting viral and cellular mechanisms
    Abou Staiteieh, Soumaiah
    Faddoul, Nouria
    Hayar, Berthe
    Houshaymi, Bilal
    Darwiche, Nadine
    Abou Merhi, Raghida
    EXPERT REVIEW OF ANTICANCER THERAPY, 2025, 25 (04) : 363 - 381
  • [25] Classic KSHV/HHV-8-positive Primary Effusion Lymphoma (PEL): A Systematic Review and Meta-Analysis of Case Reports
    Cozzi, Ilaria
    Rossi, Giovanni
    Rullo, Emma
    Ascoli, Valeria
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
  • [26] Primary effusion lymphoma and Kaposi's sarcoma in an HIV-infected man
    Lankester, KJ
    Lishman, S
    Ayliffe, U
    Kocjan, G
    Spittle, MF
    Miller, RF
    INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (10) : 616 - 618
  • [27] Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma
    Goto, Hiroki
    Kojima, Yuki
    Nagai, Hirokazu
    Okada, Seiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (05) : 624 - 633
  • [28] Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma
    Lurain, Kathryn
    Ramaswami, Ramya
    Marshall, Vickie
    Castro, Elena M. Cornejo
    Labo, Nazzarena
    Miley, Wendell
    Moore, Kyle
    Roshan, Romin
    Mangusan, Ralph
    Jaffe, Elaine S.
    Pittaluga, Stefania
    Wang, Hao-Wei
    Roth, Mark
    Filie, Armando C.
    Uldrick, Thomas S.
    Whitby, Denise
    Yarchoan, Robert
    HAEMATOLOGICA, 2023, 108 (07) : 1940 - 1944
  • [29] Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma
    Ding, Ling
    Zhu, Qing
    Zhou, Feng
    Tan, Hongsheng
    Xu, Wenjia
    Pan, Chengling
    Zhu, Caixia
    Wang, Yuyan
    Zhang, Hong
    Fu, Wenwei
    Qian, Zhikang
    Yuan, Zhenghong
    Xu, Hongxi
    Wei, Fang
    Cai, Qiliang
    PLOS PATHOGENS, 2019, 15 (12)
  • [30] KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo
    Pekkonen, Pirita
    Jarviluoma, Annika
    Zinovkina, Nadezhda
    Cvrljevic, Anna
    Prakash, Sonam
    Westermarck, Jukka
    Evan, Gerard I.
    Cesarman, Ethel
    Verschuren, Emmy W.
    Ojala, Paivi M.
    CELL CYCLE, 2014, 13 (23) : 3670 - 3684